本月全球药品研发进展取得成效的药物有43个,较上月增加了3个,除进入注册阶段的药品数量减少外,注册前和Ⅲ期临床阶段阶段的药品数量均有增加。进入注册阶段的有15个,比上月大幅减少8个。其中2个为全球首次注册的新活性物质和新制剂,其余13个均为在新市场补充注册。 There were 43 pharmaceuticals that made progress in global drug development this month, an increase of 3 from the previous month. The number of drugs before and during the phase III clinical phase increased except for the decrease in the number of drugs entering the registration phase. There were 15 in the registration phase, a sharp decrease of 8 from the previous month. Two of them were the first new active substances and new preparations registered in the world, and the remaining 13 were newly registered in the new markets.